Felbamate
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
51672-4172 -
Package NDC
51672-4172-1 -
Package NDC
51672-4172-9 -
Application number
ANDA206314 -
SPL ID
569a1960-5eb0-3efa-e063-6394a90a1c1e -
SPL set ID
0afffb17-e6ac-4bea-a90e-7ef3c8150290 -
UNII
X72RBB02N8 -
RxCUI
310285
What the source publishes
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Active ingredients
- Felbamate
- Form
- SUSPENSION
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Felbamate",
"splId": "569a1960-5eb0-3efa-e063-6394a90a1c1e",
"labels": [
{
"setId": "0afffb17-e6ac-4bea-a90e-7ef3c8150290",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0afffb17-e6ac-4bea-a90e-7ef3c8150290",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0afffb17-e6ac-4bea-a90e-7ef3c8150290"
}
],
"routes": [
"ORAL"
],
"labeler": "Sun Pharmaceutical Industries, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "237 mL in 1 BOTTLE (51672-4172-1)",
"package_ndc": "51672-4172-1",
"identifierStatus": "well-formed",
"marketing_start_date": "20170616"
},
{
"sample": false,
"description": "473 mL in 1 BOTTLE (51672-4172-9)",
"package_ndc": "51672-4172-9",
"identifierStatus": "well-formed",
"marketing_start_date": "20170616"
}
],
"productId": "51672-4172_569a1960-5eb0-3efa-e063-6394a90a1c1e",
"useDomain": "unknown",
"dosageForm": "SUSPENSION",
"productNdc": "51672-4172",
"deaSchedule": null,
"genericName": "Felbamate",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "FELBAMATE",
"strength": "600 mg/5mL"
}
],
"applicationNumber": "ANDA206314",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20170616",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175753",
"N0000008486"
],
"unii": [
"X72RBB02N8"
],
"rxcui": [
"310285"
],
"spl_set_id": [
"0afffb17-e6ac-4bea-a90e-7ef3c8150290"
],
"pharm_class_pe": [
"Decreased Central Nervous System Disorganized Electrical Activity [PE]"
],
"pharm_class_epc": [
"Anti-epileptic Agent [EPC]"
],
"manufacturer_name": [
"Sun Pharmaceutical Industries, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:51672-4172_569a1960-5eb0-3efa-e063-6394a90a1c1e"